
HIPRA Biotech Services
Interne End-to-End-Fähigkeiten von der Zelllinienentwicklung bis zur kommerziellen Fertigung.
Services: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services
Markets: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)
Compliance: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
BSL (Biological Safety Level): 1, 2
Use: Human
Batch Size: Large, Small, Medium
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Region: Europe
Category / Product: BIOLOGICS

Services: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services
Markets: EMA (EU)
Compliance: ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)
BSL (Biological Safety Level): 1, 2
Use: Human
Batch Size: Large, Medium
Therapeutic Areas of Expertise (ATC): (J) Antiinfectives for systemic use, (R) Respiratory system, (G) Genito urinary system and sex hormones
Category / Product: FDF / DRUG PRODUCTS, BIOLOGICS
Region: Europe

Green Phoenix Labs GmbH
Lizenzierter ATMP-Standort in Deutschland. GMP-Herstellung und QP-Chargenfreigabe für Zell- und Gewebetherapien.
Services: Development services, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services
Markets: EMA (EU)
BSL (Biological Safety Level): 1, 2
Use: Human
Controlled Substances: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse
Therapeutic Areas of Expertise (ATC): (S) Sensory organs, (N) Nervous system, (D) Dermatologicals, (B) Blood and blood forming organs, (R) Respiratory system, (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Batch Size: Small, Medium
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Compliance: EMA (EU GMP)
Category / Product: FDF / DRUG PRODUCTS, SERVICES, BIOLOGICS
Region: Europe

HIPRA Biotech Services
Interne End-to-End-Fähigkeiten von der Zelllinienentwicklung bis zur kommerziellen Fertigung.
Services: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services
Markets: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)
Compliance: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
BSL (Biological Safety Level): 1, 2
Use: Human, Veterinary
Batch Size: Large, Small, Medium
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Category / Product: FDF / DRUG PRODUCTS, BIOLOGICS
Region: Europe

Senn Chemicals
Schweizer Forschungs- und Entwicklungsstandort für Peptide und Peptidzwischenprodukte mit SPPS, LPPS, Hybridsynthese, Maßstabsvergrößerung im Kilolabor, Reinigu
Services: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
Region: Europe
Category / Product: COSMETICS, CHEMICAL-SYNTHETIC, SERVICES, PARTICLE ENGINEERING
Batch Size: Small

Senn Chemicals
Kleines GMP-Peptid- und organisches Syntheselabor für klinische, Nischen- und hochwertige Projekte, die eine flexible cGMP-Produktion erfordern.
Services: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
Region: Europe
Category / Product: CHEMICAL-SYNTHETIC, PARTICLE ENGINEERING
Batch Size: Small

Senn Chemicals
Schweizer cGMP-Produktionsstandort für die Herstellung von LPPS, SPPS und Hybridpeptiden vom Pilot- bis zum frühen kommerziellen Maßstab.
Services: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
Region: Europe
Batch Size: Large, Medium
Category / Product: CHEMICAL-SYNTHETIC, PARTICLE ENGINEERING

Senn Chemicals
Groß angelegter Nicht-GMP-Produktionsstandort für Peptid-Zwischenprodukte, organische Synthese, LPPS-Betriebe und Scale-up-Produktion.
Services: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
Region: APAC
Batch Size: Large, Small, Medium
Category / Product: COSMETICS, CHEMICAL-SYNTHETIC, SERVICES, PARTICLE ENGINEERING

Senn Chemicals
Forschungs- und Entwicklungszentrum für Peptid- und organische Chemie mit Unterstützung für SPPS, Reinigung, Lyophilisierung, Analytik und Partikeltechnik.
Services: Logistics, Development services, Analytical / QC services, Quality Assurance services, Packaging
Region: APAC
Category / Product: CHEMICAL-SYNTHETIC, PARTICLE ENGINEERING
Batch Size: Small

VIVEbiotech
Ihr führender GMP-zertifizierter CDMO, der sich ausschließlich der Produktion lentiviraler Vektoren widmet.
Markets: EMA (EU), FDA (USA), MHRA (UK)
Region: Europe
Compliance: FDA (cGMP), French Service-Public (CIR), EMA (EU GMP), MHRA (UK GMP)
Batch Size: Large, Small, Medium
Use: Human
BSL (Biological Safety Level): 1, 2
Services: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
Category / Product: BIOLOGICS
Probio
Globaler GCT- und Biologika-CDMO, der Ihre Pipeline vom Gen zum kommerziellen Markt beschleunigt.
Region: APAC
Compliance: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), EMA (EU GMP)
Batch Size: Large, Small, Medium
Use: Human
Category / Product: BIOLOGICS

Cultiply
Spanisches CDMO, das Produktions- und Reinigungsverfahren für rekombinante Proteine, Enzyme, DNA und andere biologisch gewonnene Produkte entwickelt.
Markets: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), CDSCO (India), TGA (Australia)
Region: Europe
Compliance: ISO
BSL (Biological Safety Level): 1, 2
Services: Development services, Manufacturing services
Controlled Substances: Lowest potential for abuse
Batch Size: Small, Medium
Category / Product: BIOLOGICS
OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day)
Register to unlock the full catalog with contact details and locations.
+80 more facilities
Create free accountSind Sie ein pharmazeutisches Unternehmen und suchen einen zuverlässigen CMO- oder CDMO-Partner, um Ihren Arzneimittelentwicklungsprozess zu beschleunigen? Suchen Sie nicht weiter als MAI CDMO Network. Unsere fortschrittliche Suchplattform verbindet Sie mit einem umfangreichen Netzwerk von qualifizierten Auftragsherstellern und Entwicklungsorganisationen weltweit.
Warum MAI CDMO Network wählen?
So funktioniert MAI CDMO Network
Die wichtigsten Vorteile einer Partnerschaft mit einer CMO/CDMO
Ausgewählte Dienstleistungen
Sind Sie bereit, Ihren idealen CMO/CDMO-Partner zu finden? Jetzt registrieren
Erkunden Sie noch heute unsere Plattform und entdecken Sie, wie MAI CDMO Network Ihnen helfen kann, Ihre Ziele in der Arzneimittelentwicklung zu erreichen.